Related Experiment Video
Updated: Sep 8, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
SensRORing cholesterol to drive protumoral myelopoiesis
Sara Gennari1, Luigi Nezi2, Teresa Manzo1
1Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy.
Abstract:
Protumoral myelopoiesis is a determinant of immunoevasion and tumor spread in many malignancies. In a recent issue of Cancer Discovery, Bleve and colleagues point to cholesterol-driven RORγ activation as the molecular trigger of myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) expansion, resulting in defective antitumor response and disease progression.
More Related Videos
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells